<DOC>
	<DOCNO>NCT01404572</DOCNO>
	<brief_summary>The purpose study compare sweetness 2 new atazanavir powder oral use ( POU ) formulation current atazanavir POU healthy participant select 1 atazanavir POU sweetness similar current atazanavir POU .</brief_summary>
	<brief_title>Taste Assessment Study 2 Atazanavir Powder Formulations Healthy Subjects</brief_title>
	<detailed_description>This study taste assessment study design select new atazanavir powder oral use ( POU ) formulation similar sweetness current POU formulation . Participants taste spit POU formulation , without swallow . Study Classification : Other . This taste study</detailed_description>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<criteria>Key inclusion criterion : Healthy men woman , age 18 49 , inclusive Nonsmokers Women pregnant breastfeeding Participants could match solution sweetness provide consistent sweetness score taste screen Key exclusion criterion : Any significant acute chronic medical illness Any acute chronic condition may alter taste sensory perception Any major surgery trauma within 4 week Day 1 Blood transfusion within 4 week study participation Recent ( within 6 month Day 1 ) drug alcohol abuse define Diagnostic Statistical Manual , 4th edition , Diagnostic Criteria Drug Alcohol Abuse Positive urine drug screen Positive urine screen cotinine Positive hepatitis C antibody , hepatitis B surface antigen , human immunodeficiency virus antibody Clinically significant elevation result liver function test normal range</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>